| Evan L Fogel, MD | |
|
550 University Blvd, Uh4100, Indianapolis, IN 46202-5149 | |
| (317) 278-6997 | |
| Not Available |
| Full Name | Evan L Fogel |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 33 Years |
| Location | 550 University Blvd, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164486684 | NPI | - | NPPES |
| 200120400 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01045682 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Diagnostic Associates Inc | 3375446347 | 279 |
News Archive
In type 2 diabetes, which is occurring at alarming rates, the hormone insulin does not work effectively to lower blood sugars and patients also do not make enough insulin. These two processes have been widely considered as separate.
In a paper published this week in the premier open-access global health journal PLoS Medicine, Majid Ezzati and colleagues from Harvard School of Public Health conclude that a large proportion of the world's population who live in low-income and middle-income countries should be the focus for intervention against risk factors for cardiovascular disease because major cardiovascular risk factors will increasingly be concentrated in these populations.
What's the best way to stop type 2 diabetes? Find it before it becomes a problem. "The phrase I use is prevention by detection," said Joseph Aloi, M.D., section chief of endocrinology and metabolism at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina.
Imagine having to face the daily struggle of taking six or more different medications a day to manage a chronic health condition; add to this the worry of missing or taking a dose incorrectly. For Anthem Blue Cross (Anthem) Medi-Cal members, that daily struggle will now be simplified to help increase medication adherence and reduce medication errors.
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease.
› Verified 2 days ago
| Entity Name | University Medical Diagnostic Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861441537 PECOS PAC ID: 3375446347 Enrollment ID: O20040202000510 |
News Archive
In type 2 diabetes, which is occurring at alarming rates, the hormone insulin does not work effectively to lower blood sugars and patients also do not make enough insulin. These two processes have been widely considered as separate.
In a paper published this week in the premier open-access global health journal PLoS Medicine, Majid Ezzati and colleagues from Harvard School of Public Health conclude that a large proportion of the world's population who live in low-income and middle-income countries should be the focus for intervention against risk factors for cardiovascular disease because major cardiovascular risk factors will increasingly be concentrated in these populations.
What's the best way to stop type 2 diabetes? Find it before it becomes a problem. "The phrase I use is prevention by detection," said Joseph Aloi, M.D., section chief of endocrinology and metabolism at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina.
Imagine having to face the daily struggle of taking six or more different medications a day to manage a chronic health condition; add to this the worry of missing or taking a dose incorrectly. For Anthem Blue Cross (Anthem) Medi-Cal members, that daily struggle will now be simplified to help increase medication adherence and reduce medication errors.
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Evan L Fogel, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Evan L Fogel, MD 550 University Blvd, Uh4100, Indianapolis, IN 46202-5149 Ph: (317) 278-6997 |
News Archive
In type 2 diabetes, which is occurring at alarming rates, the hormone insulin does not work effectively to lower blood sugars and patients also do not make enough insulin. These two processes have been widely considered as separate.
In a paper published this week in the premier open-access global health journal PLoS Medicine, Majid Ezzati and colleagues from Harvard School of Public Health conclude that a large proportion of the world's population who live in low-income and middle-income countries should be the focus for intervention against risk factors for cardiovascular disease because major cardiovascular risk factors will increasingly be concentrated in these populations.
What's the best way to stop type 2 diabetes? Find it before it becomes a problem. "The phrase I use is prevention by detection," said Joseph Aloi, M.D., section chief of endocrinology and metabolism at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina.
Imagine having to face the daily struggle of taking six or more different medications a day to manage a chronic health condition; add to this the worry of missing or taking a dose incorrectly. For Anthem Blue Cross (Anthem) Medi-Cal members, that daily struggle will now be simplified to help increase medication adherence and reduce medication errors.
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease.
› Verified 2 days ago
Irene A Carrothers, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1701 Senate Blvd, Indianapolis, IN 46202 Phone: 317-963-8776 Fax: 317-963-5285 | |
Liam P Howley, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1001 West 10th St Opw-m200, Indiana University Department Of Medicine, Indianapolis, IN 46202 Phone: 317-630-6560 | |
Cristina Nancy Perez Chumbiauca, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-5000 | |
Dr. Andrew Jonathen Ortega, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 702 Rotary Cir, Indianapolis, IN 46202 Phone: 317-278-4427 | |
Lawrence John Born, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8424 Naab Rd, #3-j, Indianapolis, IN 46260 Phone: 317-872-7396 Fax: 317-879-8328 | |
Brian T Robinson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-7979 Fax: 317-630-2668 | |
Steven T Hugenberg, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-8660 |